These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1823743)

  • 41. Plasma norepinephrine in Chagas' cardioneuromyopathy: a marker of progressive dysautonomia.
    Iosa D; DeQuattro V; Lee DD; Elkayam U; Palmero H
    Am Heart J; 1989 Apr; 117(4):882-7. PubMed ID: 2494874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy.
    Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM
    Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sudden cardiac death in Chagas' heart disease in the contemporary era.
    Bestetti RB; Cardinalli-Neto A
    Int J Cardiol; 2008 Dec; 131(1):9-17. PubMed ID: 18692919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parasympathetic impairment in the preclinical stage of chronic Chagas disease.
    Bestetti RB; Cardinalli Neto A; Nogueira PR
    Arq Bras Cardiol; 2012 Sep; 99(3):867; author reply 868-9. PubMed ID: 23011195
    [No Abstract]   [Full Text] [Related]  

  • 45. Autonomic nervous system activity and psychiatric severity in schizophrenia.
    Fujibayashi M; Matsumoto T; Kishida I; Kimura T; Ishii C; Ishii N; Moritani T
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):538-45. PubMed ID: 19496998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical utility of QT interval assessment in diabetes.
    Veglio M; Chinaglia A; Cavallo Perin P
    Diabetes Nutr Metab; 2000 Dec; 13(6):356-65. PubMed ID: 11232762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human antibodies with muscarinic activity modulate ventricular repolarization: basis for electrical disturbance.
    Medei E; Pedrosa RC; Benchimol Barbosa PR; Costa PC; Hernández CC; Chaves EA; Linhares V; Masuda MO; Nascimento JH; Campos de Carvalho AC
    Int J Cardiol; 2007 Feb; 115(3):373-80. PubMed ID: 16884792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Coronary microvascular changes in Chagas' disease].
    Rossi MA; Ramos SG
    Arq Bras Cardiol; 1996 Mar; 66(3):169-72. PubMed ID: 8762698
    [No Abstract]   [Full Text] [Related]  

  • 51. A summary perspective on the clinical-functional significance of cardiac autonomic dysfunction in Chagas' disease.
    Junqueira LF
    Rev Soc Bras Med Trop; 2006; 39 Suppl 3():64-9. PubMed ID: 17605211
    [No Abstract]   [Full Text] [Related]  

  • 52. Heart-brain interactions in cardiac arrhythmia.
    Taggart P; Critchley H; Lambiase PD
    Heart; 2011 May; 97(9):698-708. PubMed ID: 21367742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The challenge of chagasic cardiomyopathy. The pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications.
    Rossi MA; Bestetti RB
    Cardiology; 1995; 86(1):1-7. PubMed ID: 7728781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac innervation and sudden cardiac death.
    Fukuda K; Kanazawa H; Aizawa Y; Ardell JL; Shivkumar K
    Circ Res; 2015 Jun; 116(12):2005-19. PubMed ID: 26044253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac dysautonomia and pathogenesis of Chagas' heart disease.
    Marin-Neto JA
    Int J Cardiol; 1998 Sep; 66(2):129-31. PubMed ID: 9829323
    [No Abstract]   [Full Text] [Related]  

  • 56. Insights into the clinical and functional significance of cardiac autonomic dysfunction in Chagas disease.
    Junqueira LF
    Rev Soc Bras Med Trop; 2012; 45(2):243-52. PubMed ID: 22535000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of autonomic nervous system function with spectral analysis of heart rate variability in a case of tetanus.
    Goto T; Fukushima H; Sasaki G; Matsuo N; Takahashi T
    Brain Dev; 2001 Dec; 23(8):791-5. PubMed ID: 11720795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chagas' disease and the involvement of the autonomic nervous system.
    da Cunha AB
    Rev Port Cardiol; 2003 Jun; 22(6):813-24. PubMed ID: 14526698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lesions of mediastinal paraganglia in chronic chagasic cardiomyopathy: cause of sudden death?
    Ramos SG; Matturri L; Rossi L; Rossi MA
    Am Heart J; 1996 Feb; 131(2):417-20. PubMed ID: 8579048
    [No Abstract]   [Full Text] [Related]  

  • 60. Natural history of chronic Chagas' heart disease: prognosis factors.
    Mady C; Nacruth R
    Sao Paulo Med J; 1995; 113(2):791-6. PubMed ID: 8650478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.